ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy.

Martin Skarzynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.